IL104745A0 - 90k tumor-associated antigen,method for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

90k tumor-associated antigen,method for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL104745A0
IL104745A0 IL104745A IL10474593A IL104745A0 IL 104745 A0 IL104745 A0 IL 104745A0 IL 104745 A IL104745 A IL 104745A IL 10474593 A IL10474593 A IL 10474593A IL 104745 A0 IL104745 A0 IL 104745A0
Authority
IL
Israel
Prior art keywords
tumor
preparation
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL104745A
Original Assignee
Univ New York
Uni Degli Studi G D Annunzio C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York, Uni Degli Studi G D Annunzio C filed Critical Univ New York
Publication of IL104745A0 publication Critical patent/IL104745A0/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IL104745A 1992-02-17 1993-02-16 90k tumor-associated antigen,method for the preparation thereof and pharmaceutical compositions containing the same IL104745A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920099A IT1264490B (en) 1992-02-17 1992-02-17 90K ANTIGEN ASSOCIATED WITH CANCER.

Publications (1)

Publication Number Publication Date
IL104745A0 true IL104745A0 (en) 1993-06-10

Family

ID=11400690

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104745A IL104745A0 (en) 1992-02-17 1993-02-16 90k tumor-associated antigen,method for the preparation thereof and pharmaceutical compositions containing the same

Country Status (6)

Country Link
CN (1) CN1076629A (en)
AU (2) AU3629093A (en)
IL (1) IL104745A0 (en)
IT (1) IT1264490B (en)
WO (2) WO1993017119A2 (en)
ZA (1) ZA931100B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2175922A1 (en) * 1993-11-05 1995-05-11 Stefano Iacobelli Methods relating to ir-95
CN1313603C (en) * 2004-09-30 2007-05-02 北京大学人民医院 Human ovary carcinoma resisting monoclonal antibody hybridoma cell line and its monoclonal antibody and application
GB2435882A (en) * 2006-03-09 2007-09-12 Bioinvent Int Ab Detection and treatment of mantle cell lymphoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76877A (en) * 1984-11-02 1991-11-21 Oncogen Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies
IT1239719B (en) * 1990-04-23 1993-11-15 Univ Degli Studi Annunzio USE OF THE SP-2 MONOCLONAL ANTIBODY IN CLINICAL DIAGNOSTICS AND THE MONITORING OF THE PROGRESS OF HIV INFECTION

Also Published As

Publication number Publication date
AU3497993A (en) 1993-09-03
ITRM920099A0 (en) 1992-02-17
CN1076629A (en) 1993-09-29
AU3629093A (en) 1993-09-13
WO1993017119A2 (en) 1993-09-02
WO1993016181A1 (en) 1993-08-19
IT1264490B (en) 1996-09-24
ITRM920099A1 (en) 1993-08-18
ZA931100B (en) 1994-08-17

Similar Documents

Publication Publication Date Title
HUP9603495A3 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
IL106600A0 (en) Peptides,pharmaceutical compositions containing the same and processes for the preparation thereof
IL108873A0 (en) 2-debenzoyl-2-acyl taxol derivatives, pharmaceutical compositions containing the same, and methods for the preparation thereof
IL110376A0 (en) Pharmaceutical compositions containing ifetroban and methods for the preparation thereof
HUP9904046A3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing the same
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL98873A0 (en) Benzodiazepine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL111533A0 (en) Quinoxalinedione derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
EP0570328A3 (en) Dispersible polydextrose, compositions containing same and method for the preparation thereof
IL105348A0 (en) Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
PH31073A (en) Pharmaceutical composition and process for the preparation thereof.
AU3635693A (en) 1,4-dialkylpiperazine derivatives, method for obtaining them and pharmaceutical compositions containing them
HUP9901485A2 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
GB2245890B (en) Basic aluminium antiperspirant active materials, antiperspirant active compositions comprising the same and methods for the preparation thereof
IL107358A0 (en) a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
IL115272A0 (en) Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof
IL104471A0 (en) Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
IL124490A0 (en) Pesticide compounds compositions and process for the preparation thereof
IL107808A0 (en) Diarylalkane derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
IL104745A0 (en) 90k tumor-associated antigen,method for the preparation thereof and pharmaceutical compositions containing the same
IL104424A0 (en) Pyrrolylbenzodiazepinones,their preparation and pharmaceutical compositions containing them
IL104525A0 (en) 4-cinnolinyl-and 4-naphthyridinyl-dihydropyridines,their preparation and pharmaceutical compositions containing them
IL115537A0 (en) Phosphonosulfonate salts pharmaceutical compositions containing the same and methods for the preparation thereof
IL116504A0 (en) 14, 17-C2-bridged steroids and pharmaceutical compositions containing the same